Non-Invasive Tumor Genotyping Using Radiogenomic Biomarkers, a Systematic Review and Oncology-Wide Pathway Analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works

The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis

Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,759 · see citing works

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703 · see citing works

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199 · see citing works

Sorafenib in advanced hepatocellular carcinoma

Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097 · see citing works

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · see citing works

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., TAPHOORN, M. J. B., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Bélanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,667 · see citing works

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · see citing works

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405 · see citing works

KEGG as a reference resource for gene and protein annotation

Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387 · see citing works

A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib

Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974 · see citing works

<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas

Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063 · see citing works

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works

The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository

Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., et al. (2013) · Journal of Digital Imaging · doi:10.1007/s10278-013-9622-7 · Cited by 4,599 · see citing works

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,023 · see citing works

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622 · see citing works

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381 · see citing works

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

Rosell, R., Moran, T., Queralt, C., Porta, R., Cardenal, F., Camps, C., Majem, M., Lopez-Vivanco, G., Isla, D., Provencio, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904554 · Cited by 2,373 · see citing works

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M. A., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,873 · see citing works

VEGF-targeted therapy: mechanisms of anti-tumour activity

Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673 · see citing works

Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. E. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,605 · see citing works

Targeting PI3K/Akt/mTOR Signaling in Cancer

Porta, C., Paglino, C., & Mosca, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00064 · Cited by 1,494 · see citing works

KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

Lièvre, A., Bachet, J., Boige, V., Cayre, A., Corre, D. L., Buc, E., Ychou, M., Bouché, O., Landi, B., Louvet, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5906 · Cited by 1,456 · see citing works

VEGF targets the tumour cell

Goel, H. L., & Mercurio, A. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3627 · Cited by 1,258 · see citing works

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

van den Bent, M. J., Brandes, A. A., TAPHOORN, M. J. B., Kros, J. M., Kouwenhoven, M. C. M., Delattre, J., Bernsen, H. J. J. A., Frénay, M., Tijssen, C. C., Grisold, W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2229 · Cited by 1,220 · see citing works

Targeting RAS–ERK signalling in cancer: promises and challenges

Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163 · see citing works

Targeting PI3K/mTOR Signaling in Cancer

Arcaro, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00084 · Cited by 1,024 · see citing works

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2682 · Cited by 839 · see citing works

Mutational landscape and clonal architecture in grade II and III gliomas

Suzuki, H., Aoki, K., Chiba, K., Sato, Y., Shiozawa, Y., Shiraishi, Y., Shimamura, T., Niida, A., Motomura, K., Ohka, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3273 · Cited by 831 · see citing works

Correlation of O 6 -Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

Hegi, M. E., Liu, L., Herman, J. G., Stupp, R., Wick, W., Weller, M., Mehta, M. P., & Gilbert, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5964 · Cited by 811 · see citing works

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Cairncross, G. J., Berkey, B. A., Shaw, E., Jenkins, R. B., Scheithauer, B. W., Brachman, D. G., Buckner, J. C., Fink, K., Souhami, L., Laperierre, N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3414 · Cited by 726 · see citing works

Decoding global gene expression programs in liver cancer by noninvasive imaging

Segal, E., Sirlin, C. B., Ooi, C., Adler, A. S., Gollub, J., Chen, X., Chan, B. K., Matcuk, G. R., Barry, C. T., Chang, H. Y., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1306 · Cited by 629 · see citing works

Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer

Sequist, L. V. D., Bell, D. W., Lynch, T. J., & Haber, D. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3585 · Cited by 617 · see citing works

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

Weller, M., Felsberg, J., Hartmann, C. J., Berger, H., Steinbach, J. P., Schramm, J., Westphal, M., Schackert, G., Simon, M., Tonn, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0805 · Cited by 615 · see citing works

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

Kapur, P., Peña‐Llopis, S., Christie, A. L., Zhrebker, L., Pavía-Jiménez, A., Rathmell, W. K., Xie, X., & Brugarolas, J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70584-3 · Cited by 466 · see citing works

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Li, H., Zhu, Y., Burnside, E. S., Drukker, K., Hoadley, K. A., Fan, C., Conzen, S. D., Whitman, G. J., Sutton, E. J., Net, J., et al. (2016) · Radiology · doi:10.1148/radiol.2016152110 · Cited by 463 · see citing works

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., Aldape, K., Cha, S., & Kuo, M. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801279105 · Cited by 440 · see citing works

Detection of 2-Hydroxyglutarate in <i>IDH</i> -Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy

Andronesi, O. C., Kim, G. S., Gerstner, E., Batchelor, T., Tzika, A. A., Fantin, V. R., Vander Heiden, M. G., & Sorensen, A. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002693 · Cited by 438 · see citing works

MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set

Gutman, D. A., Cooper, L., Hwang, S. N., Holder, C. A., Gao, J., Aurora, T. D., Dunn, W. D., Scarpace, L. M., Mikkelsen, T., Jain, R., et al. (2013) · Radiology · doi:10.1148/radiol.13120118 · Cited by 417 · see citing works

Non–Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data—Methods and Preliminary Results

Gevaert, O., Xu, J., Hoang, C. D., Leung, A. N. C., Xu, Y., Quon, A. S. W., Rubin, D. L., Napel, S. A., & Plevritis, S. K. (2012) · Radiology · doi:10.1148/radiol.12111607 · Cited by 395 · see citing works

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208622 · Cited by 357 · see citing works

A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma

Banerjee, S., Wang, D. S., Kim, H. J., Sirlin, C. B., Chan, M. G., Korn, R. L., Rutman, A. M., Siripongsakun, S., Lu, D., Imanbayev, G., et al. (2015) · Hepatology · doi:10.1002/hep.27877 · Cited by 354 · see citing works

MRI Surrogates for Molecular Subgroups of Medulloblastoma

Perreault, S., Ramaswamy, V., Achrol, A. S., Chao, K., Liu, T. T., Shih, D. J. H., Remke, M., Schubert, S., Bouffet, É., Fisher, P. G., et al. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3990 · Cited by 324 · see citing works

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Shin, D., Na, I. I., Kim, C. H., Park, S., Baek, H., & Yang, S. H. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000069 · Cited by 319 · see citing works

Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features

Gevaert, O., Mitchell, L. A., Achrol, A. S., Xu, J., Echegaray, S., Steinberg, G. K., Cheshier, S. H., Napel, S., Zaharchuk, G., & Plevritis, S. K. (2014) · Radiology · doi:10.1148/radiol.14131731 · Cited by 319 · see citing works

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

Pope, W. B., Prins, R. M., Albert Thomas, M., Nagarajan, R., Yen, K. E., Bittinger, M. A., Salamon, N., Chou, A. P., Yong, W. H., Soto, H., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0737-8 · Cited by 318 · see citing works

Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging

Rutman, A. M., & Kuo, M. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.01.050 · Cited by 314 · see citing works

IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma

Kickingereder, P., Sahm, F., Radbruch, A., Wick, W., Heiland, S., von Deimling, A., Bendszus, M., & Wiestler, B. (2015) · Scientific Reports · doi:10.1038/srep16238 · Cited by 314 · see citing works

Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas

Liu, Y., Kim, J., Balagurunathan, Y., Li, Q., García, A. L., Stringfield, O., Ye, Z., & Gillies, R. J. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.02.001 · Cited by 312 · see citing works

Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features

Kickingereder, P., Bonekamp, D., Nowosielski, M., Kratz, A., Sill, M., Burth, S., Wick, A., Eidel, O., Schlemmer, H., Radbruch, A., et al. (2016) · Radiology · doi:10.1148/radiol.2016161382 · Cited by 304 · see citing works

Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques

Macyszyn, L. J., Akbari, H., Pisapia, J. M., Da, X., Attiah, M. A., Pigrish, V., Bi, Y., Pal, S., Davuluri, R. V., Roccograndi, L., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov127 · Cited by 300 · see citing works

Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

Carrillo, J., Lai, A., Nghiemphu, P. L., Kim, H. J., PHILLIPS, H. S., Kharbanda, S., Moftakhar, P., Lalaezari, S., Yong, W. H., Ellingson, B. M., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2950 · Cited by 297 · see citing works

Radiogenomics: What It Is and Why It Is Important

Mazurowski, M. A. (2015) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2015.04.019 · Cited by 289 · see citing works

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

Métellus, P., Coulibaly, B., Colin, C., de Paula, A. M., Vasiljevic, A., Taïeb, D., Barlier, A., Boisselier, B., Mokhtari, K., Wang, X. W., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0777-8 · Cited by 286 · see citing works

Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography

Timmers, H. J. L. M., Chen, C. C., Carrasquillo, J. A., Whatley, M. A., Ling, A. L., Eisenhofer, G., King, K. S., Rao, J. U., WESLEY, R. A., Adams, K. T., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs188 · Cited by 278 · see citing works

Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities

Itakura, H., Achrol, A. S., Mitchell, L. A., Loya, J. J., Liu, T. T., Westbroek, E. M., Feroze, A. H., Rodriguez, S., Echegaray, S., Azad, T. D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7582 · Cited by 270 · see citing works

Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations

Karlo, C. A., Paolo, P. L. D., Chaim, J. L., Hakimi, A. A., Ostrovnaya, I., Russo, P., Hricak, H., Motzer, R. J., Hsieh, J. J.-D., & Akın, O. (2013) · Radiology · doi:10.1148/radiol.13130663 · Cited by 270 · see citing works

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

Rizzo, S., Petrella, F., Buscarino, V., Maria, F. D., Raimondi, S., Barberis, M. C. P., Fumagalli, C., Spitaleri, G., Rampinelli, C., de Marinis, F., et al. (2015) · European Radiology · doi:10.1007/s00330-015-3814-0 · Cited by 269 · see citing works

Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response

Kickingereder, P., GOETZ, M. A., Muschelli, J., Wick, A., Neuberger, U., Shinohara, R. T., Sill, M., Nowosielski, M., Schlemmer, H.-P., Radbruch, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0702 · Cited by 265 · see citing works

Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme

Zinn, P. O., Majadan, B., Sathyan, P., Singh, S. K., Majumder, S., Jolesz, F. A., & Colen, R. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025451 · Cited by 264 · see citing works

Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas

Zhang, B., Chang, K., Ramkissoon, S. H., Tanguturi, S. K., Bi, W. L., Reardon, D. A., Ligon, K. L., Alexander, B. M., Wen, P. Y., & Huang, R. Y. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now121 · Cited by 262 · see citing works

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

Reifenberger, G., Hentschel, B., Felsberg, J., Schackert, G., Simon, M., Schnell, O., Westphal, M., Wick, W., Pietsch, T., Loeffler, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27385 · Cited by 256 · see citing works

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Padfield, E., Ellis, H. P., & Kurian, K. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00005 · Cited by 244 · see citing works

Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging

Mazurowski, M. A., Zhang, J., Grimm, L. J., Yoon, S. C., & Silber, J. I. (2014) · Radiology · doi:10.1148/radiol.14132641 · Cited by 241 · see citing works

Behind the Numbers: Decoding Molecular Phenotypes with Radiogenomics—Guiding Principles and Technical Considerations

Kuo, M. D., & Jamshidi, N. (2014) · Radiology · doi:10.1148/radiol.13132195 · Cited by 238 · see citing works

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor

Jain, R., Poisson, L., Gutman, D. A., Scarpace, L. M., Hwang, S. N., Holder, C. A., Wintermark, M., Rao, A. U. K., Colen, R. R., Kirby, J., et al. (2014) · Radiology · doi:10.1148/radiol.14131691 · Cited by 235 · see citing works

Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma

Hakimi, A. A., Chen, Y., Wren, J. M., Gönen, M., Abdel-Wahab, O. I., Heguy, A., Liu, H., Takeda, S., Tickoo, S. K., Reuter, V. E., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.09.005 · Cited by 231 · see citing works

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma

Brandes, A. A., Franceschi, E., Tosoni, A., Benevento, F., Scopece, L., Mazzocchi, V., Bacci, A., Agati, R., Calbucci, F., & Ermani, M. (2009) · Cancer · doi:10.1002/cncr.24406 · Cited by 226 · see citing works

Probabilistic Radiographic Atlas of Glioblastoma Phenotypes

Ellingson, B. M., Lai, A., Harris, R. J., Selfridge, J. M., Yong, W. H., Das, K., Pope, W. B., Nghiemphu, P. L., Vinters, H. V., Liau, L. M., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3253 · Cited by 221 · see citing works

Radiogenomics to characterize regional genetic heterogeneity in glioblastoma

Hu, L., Ning, S., Eschbacher, J. M., Baxter, L. C., Gaw, N. B., Ranjbar, S., Plasencia, J. D., Dueck, A. C., Peng, S., Smith, K. A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now135 · Cited by 221 · see citing works

Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC

Aerts, H. J. W. L., Großmann, P., Tan, Y., Oxnard, G. R., Rizvi, N. A., Schwartz, L. H., & Zhao, B. (2016) · Scientific Reports · doi:10.1038/srep33860 · Cited by 213 · see citing works

Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma

Yu, J., Shi, Z., Lian, Y., Li, Z., Liu, T., Gao, Y., Wang, Y., Chen, L., & Mao, Y. Q. (2016) · European Radiology · doi:10.1007/s00330-016-4653-3 · Cited by 213 · see citing works

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging

Drabycz, S., Roldán, G. B., de Robles, P. A., Adler, D. H., McIntyre, J. B., Magliocco, A. M., Cairncross, J. G., & Mitchell, J. R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.09.049 · Cited by 206 · see citing works

PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer

Prat, A., Parker, J. S., Fan, C., & Perou, C. M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2143-0 · Cited by 194 · see citing works

Molecular Profiling for Breast Cancer: A Comprehensive Review

Kittaneh, M., Montero, A. J., & Glück, S. (2013) · Biomarkers in Cancer · doi:10.4137/bic.s9455 · Cited by 190 · see citing works

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

de la Fuente, M. I., Young, R. J., Rubel, J., Rosenblum, M. K., Tisnado, J., Briggs, S. R., Perez, J. A., Cross, J. R., Campos, C., Straley, K. S., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov307 · Cited by 190 · see citing works

Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20

Tang, G., Shak, S., Paik, S., Anderson, S., Costantino, J. P., Geyer, C. E., Mamounas, E. P., Wickerham, D. L., & Wolmark, N. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1331-z · Cited by 187 · see citing works

Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations

Hartmann, C. J., Hentschel, B., Simon, M., Westphal, M., Schackert, G., Tonn, J. C., Loeffler, M., Reifenberger, G., Pietsch, T., von Deimling, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0017 · Cited by 186 · see citing works

Novel therapeutic targets on the horizon for lung cancer

Tan, W.-L., Jain, A., Takano, A. M., Newell, E. W., Iyer, N. G., Lim, W., Tan, E.-H., Zhai, W., Hillmer, A. M., Tam, W. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30123-1 · Cited by 184 · see citing works

Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinomas: Relationship with CT Characteristics and Histologic Subtypes

Lee, H.-J., Kim, Y. T., Kang, C. H., Zhao, B., Tan, Y., Schwartz, L. H., ten Persigehl, T., Jeon, Y. K., & Chung, D. H. (2013) · Radiology · doi:10.1148/radiol.13112553 · Cited by 176 · see citing works

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

Lassman, A. B., IWAMOTO, F. M., Cloughesy, T. F., Aldape, K., Rivera, A. L., Eichler, A. F., Louis, D. N., Paleologos, N. A., Fisher, B. J., Ashby, L., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor040 · Cited by 175 · see citing works

Radiogenomic Analysis of Breast Cancer Using MRI: A Preliminary Study to Define the Landscape

Yamamoto, S., Maki, D. D., Korn, R. L., & Kuo, M. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7824 · Cited by 174 · see citing works

Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate

Andronesi, O. C., Rapalino, O., Gerstner, E. R., Chi, A. S., Batchelor, T. T., Cahill, D. P., Sorensen, A. G., & Rosen, B. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67229 · Cited by 174 · see citing works

Radiogenomic Analysis to Identify Imaging Phenotypes Associated with Drug Response Gene Expression Programs in Hepatocellular Carcinoma

Kuo, M. D., Gollub, J., Sirlin, C. B., Ooi, C., & Chen, X. (2007) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2007.04.031 · Cited by 168 · see citing works

Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma

Zhu, Y., Li, H., Guo, W., Drukker, K., Lan, L., Giger, M. L., & Ji, Y. (2015) · Scientific Reports · doi:10.1038/srep17787 · Cited by 165 · see citing works

Glioblastoma Multiforme Regional Genetic and Cellular Expression Patterns: Influence on Anatomic and Physiologic MR Imaging

Barajas, R., Hodgson, J., Chang, J. S., VandenBerg, S. R., Yeh, R.-F., Parsa, A. T., McDermott, M. W., Berger, M. S., Dillon, W. P., & Cha, S. (2010) · Radiology · doi:10.1148/radiol.09090663 · Cited by 163 · see citing works

Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features

Jenkinson, M. D. (2006) · Brain · doi:10.1093/brain/awl108 · Cited by 162 · see citing works

Predictive radiogenomics modeling of EGFR mutation status in lung cancer

Gevaert, O., Echegaray, S., Khuong, A., Hoang, C. D., Shrager, J. B., Jensen, K. C., Berry, G. J., Guo, H. H., Lau, C., Plevritis, S. K., et al. (2017) · Scientific Reports · doi:10.1038/srep41674 · Cited by 160 · see citing works

ALKMolecular Phenotype in Non–Small Cell Lung Cancer: CT Radiogenomic Characterization

Yamamoto, S., Korn, R. L., Öklü, R., Migdal, C., Gotway, M. B., Weiss, G. J., Iafrate, A. J., Kim, D., & Kuo, M. (2014) · Radiology · doi:10.1148/radiol.14140789 · Cited by 159 · see citing works

Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression Profiles

Ashraf, A. B., Daye, D., Gavenonis, S. C., Mies, C., Feldman, M. D., Rosen, M. A., & Despina Kontos, B. (2014) · Radiology · doi:10.1148/radiol.14131375 · Cited by 151 · see citing works

Relationship between Gene Expression and Enhancement in Glioblastoma Multiforme: Exploratory DNA Microarray Analysis

Pope, W. B., Chen, J. H., Dong, J., Carlson, M. R. J., Perlina, A., Cloughesy, T. F., Liau, L. M., Mischel, P. S., Nghiemphu, P. L., Lai, A., et al. (2008) · Radiology · doi:10.1148/radiol.2491072000 · Cited by 149 · see citing works

Imaging Correlates of Molecular Signatures in Oligodendrogliomas

Megyesi, J. F., Kachur, E., Lee, D. H., Ƶlatescu, M. C., Betensky, R. A., Forsyth, P. A., Okada, Y., Sasaki, H., Mizoguchi, M., Louis, D. N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0209 · Cited by 149 · see citing works

MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification

Brisson, M., Kashima, T. G., Delaney, D., Tirabosco, R., Clarke, A. W., Cro, S., Flanagan, A. M., & O’Donnell, P. (2012) · Skeletal Radiology · doi:10.1007/s00256-012-1517-z · Cited by 146 · see citing works

Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth

Kobayashi, Y., Mitsudomi, T., Sakao, Y., & Yatabe, Y. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu505 · Cited by 141 · see citing works

Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas

Ellingson, B. M., Cloughesy, T. F., Pope, W. B., Zaw, T. M., PHILLIPS, H. S., Lalezari, S., Nghiemphu, P. L., Ibrahim, H., Naeini, K. M., Harris, R. J., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.076 · Cited by 139 · see citing works

Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay

Sutton, E. J., Oh, J. H., Dashevsky, B. Z., Veeraraghavan, H., Apte, A., Thakur, S. B., Deasy, J. O., & Morris, E. A. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24890 · Cited by 138 · see citing works

Hypoxia-Induced Gene Expression in Chemoradioresistant Cervical Cancer Revealed by Dynamic Contrast-Enhanced MRI

Halle, C., Andersen, E. K. F., Lando, M., Aarnes, E., Hasvold, G., Holden, M., Syljuåsen, R. G., Sundfør, K., Kristensen, G. B., Holm, R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1085 · Cited by 138 · see citing works

Prognostic PET 18F-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non–Small Cell Lung Cancer

Nair, V. S., Gevaert, O., Davidzon, G., Napel, S. A., Graves, E. E., Hoang, C. D., Shrager, J. B., Quon, A. S. W., Rubin, D. L., & Plevritis, S. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3943 · Cited by 135 · see citing works

Illuminating Radiogenomic Characteristics of Glioblastoma Multiforme through Integration of MR Imaging, Messenger RNA Expression, and DNA Copy Number Variation

Jamshidi, N., Diehn, M., Bredel, M., & Kuo, M. (2013) · Radiology · doi:10.1148/radiol.13130078 · Cited by 131 · see citing works

18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?

Taïeb, D., Sebag, F. A., Barlier, A., Tessonnier, L., Palazzo, F. F., Morange, I., Niccoli, P., Fakhry, N., Micco, C. D., Cammilleri, S., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060731 · Cited by 126 · see citing works

The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma

Brown, R. A., Ƶlatescu, M. C., Sijben, A. E. J., Roldán, G. B., Easaw, J., Forsyth, P. A., Parney, I. F., Sevick, R. J., Yan, E., Demetrick, D. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1964 · Cited by 123 · see citing works

18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers

Palaskas, N. J., Larson, S. M., Schultz, N. D., Komisopoulou, E., Wong, J., Rohle, D., Campos, C., Yannuzzi, N. A., Osborne, J. R., Linkov, I., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4633 · Cited by 123 · see citing works

MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status

Yamashita, K., Hiwatashi, A., Togao, O., Kikuchi, K., Hatae, R., Yoshimoto, K., Mizoguchi, M., Suzuki, S. O., Yoshiura, T., & Honda, H. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4491 · Cited by 123 · see citing works

Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging

Moon, W., Choi, J. W., Roh, H. G., Lim, S. D., & Koh, Y.-C. (2011) · Neuroradiology · doi:10.1007/s00234-011-0947-y · Cited by 122 · see citing works

Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Intrapulmonary Spread

Chung, J.-H., Choe, G., Jheon, S., Sung, S. W., Kim, T. J., Lee, K. W., Lee, J. H., & Lee, C. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181bc9731 · Cited by 121 · see citing works

Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic

Weiss, G. J., Ganeshan, B., Miles, K. A., Campbell, D. H., Cheung, P. Y.-C., Frank, S., & Korn, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100244 · Cited by 120 · see citing works

Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis

Yamamoto, S., Han, W., Kim, Y., Du, L., Jamshidi, N., Huang, D., Kim, J. H., & Kuo, M. (2015) · Radiology · doi:10.1148/radiol.15142698 · Cited by 120 · see citing works

Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach

Yoon, H. J., Sohn, I., Cho, J. H., Lee, H. Y., Kim, J., Choi, Y., Kim, H. S., Lee, G., Lee, K. S., & Kim, J. (2015) · Medicine · doi:10.1097/md.0000000000001753 · Cited by 120 · see citing works

Imaging genomics in cancer research: limitations and promises

Bai, H. X., Lee, A. M., Yang, L., Zhang, P. J., Davatzikos, C. A., Maris, J. M., & Diskin, S. J. (2016) · British Journal of Radiology · doi:10.1259/bjr.20151030 · Cited by 112 · see citing works

Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene

Fukui, T., Yatabe, Y., Kobayashi, Y., Tomizawa, K., Ito, S., Hatooka, S., Matsuo, K., & Mitsudomi, T. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.013 · Cited by 109 · see citing works

FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma

Chung, H. W., Lee, K. Y., Kim, H. J., Kim, W. S., & So, Y. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1545-7 · Cited by 106 · see citing works

Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis?

Fellah, S., Caudal, D., de Paula, A. M., Dory‐Lautrec, P., Figarella-Branger, D. F., Chinot, O. L., Métellus, P., Cozzone, P. J., Sylviane Confort-gouny, A., Ghattas, B., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3352 · Cited by 106 · see citing works

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Stoyanova, R. S., Pollack, A. S., Takhar, M. M., Lynne, C. M., Parra, N. A., Lam, L. L. C., Alshalalfa, M., Buerki, C., Castillo, R. P., Jordà, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10523 · Cited by 106 · see citing works

Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging

Lee, S., Choi, S. H., Ryoo, I., Yoon, T. J., Kim, T. M., Lee, S., Park, C., Kim, J., Sohn, C., Park, S., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1614-z · Cited by 104 · see citing works

Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS / BRAF Mutations in Colorectal Cancer

Kawada, K., Nakamoto, Y., Kawada, M., Hida, K., Matsumoto, T., Murakami, T., Hasegawa, S., Togashi, K., & Sakai, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1909 · Cited by 104 · see citing works

Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas–Renal Cell Carcinoma (TCGA–RCC) Imaging Research Group

Shinagare, A. B., Vikram, R., Jaffe, C. C., Akın, O., Kirby, J., Huang, E. P., Freymann, J., Sainani, N. I., Sadow, C. A., Bathala, T. K., et al. (2015) · Abdominal Imaging · doi:10.1007/s00261-015-0386-z · Cited by 101 · see citing works

Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma

Kanas, V. G., Zacharaki, E. I., Thomas, G. A., Zinn, P. O., Megalooikonomou, V., & Colen, R. R. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.12.018 · Cited by 98 · see citing works

Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status

Romano, A., Calabria, L. F., Tavanti, F., Minniti, G. C., Rossi‐Espagnet, M. C., Coppola, V., Pugliese, S., Guida, D., Francione, G., Colonnese, C., et al. (2012) · European Radiology · doi:10.1007/s00330-012-2601-4 · Cited by 97 · see citing works

Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features

Sekine, A., Kato, T., Hagiwara, E., Shinohara, T., Komagata, T., Iwasawa, T., Satoh, H., Tamura, K., Kasamatsu, T., Hayashihara, K., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.12.017 · Cited by 97 · see citing works

Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor

Takano, K., Kinoshita, M., Takagaki, M., Sakai, M., Tateishi, S., Achiha, T., Hirayama, R., Nishino, K., Uchida, J., Kumagai, T., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov266 · Cited by 95 · see citing works

Rapid Disease Progression With Delay in Treatment of Non–Small-Cell Lung Cancer

Mohammed, N., Kestin, L. L., Grills, I. S., Battu, M., Fitch, D. L., Wong, C.-Y. O., Margolis, J., Chmielewski, G. W., & Welsh, R. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.11.029 · Cited by 94 · see citing works

Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma

Yano, M., Sasaki, H., Kobayashi, Y., Yukiue, H., Haneda, H., Suzuki, E., Endo, K., Kawano, O., Hara, M., & Fujii, Y. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31604-x · Cited by 92 · see citing works

Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

Caicedo, C., García‐Velloso, M. J., Lozano, M. D., Labiano, T., Díaz, C. V., López-Picazo, J. M., Gúrpide, A., Zulueta, J. J., Richter, J. Á., & Perez‐Gracia, J. L. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2833-4 · Cited by 91 · see citing works

18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis

Osborne, J. R., Port, E. R., Gönen, M., Doane, A. S., YEUNG, H. W. D., Gerald, W. L., Cook, J., & Larson, S. M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060459 · Cited by 90 · see citing works

Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging

Ahn, S. S., Shin, N.-Y., Chang, J. H., Kim, S. H., Kim, E. H., Kim, D. W., & Lee, S. (2014) · Journal of neurosurgery · doi:10.3171/2014.5.jns132279 · Cited by 90 · see citing works

EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity

Yang, Y., Yang, Y., Zhou, X., Song, X., Liu, M., He, W., Wang, H., Wu, C., Fei, K., & Jiang, G. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2014.12.016 · Cited by 89 · see citing works

A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature

Zinn, P. O., Sathyan, P., Mahajan, B., Bruyere, J. R., Hegi, M. E., Majumder, S., & Colen, R. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041522 · Cited by 88 · see citing works

Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

Mak, R. H., Digumarthy, S. R., Muzikansky, A., Engelman, J. A., Shepard, J.-A. O., Choi, N. C., & Sequist, L. V. D. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0300 · Cited by 87 · see citing works

Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations

Zhou, J., Zheng, J., Yu, Z. F., Xiao, W. B., Zhao, J., Sun, K., Wang, B., Chen, X., Jiang, L. N., Ding, W., et al. (2015) · European Radiology · doi:10.1007/s00330-014-3516-z · Cited by 84 · see citing works

Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma

Kalinina, J., Carroll, A., Wang, L., Yu, Q., Mancheno, D. E., Wu, S., Liu, F., Ahn, J. Y., He, M., Mao, H. Z., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0888-x · Cited by 84 · see citing works

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET/CT and 18F-FDG PET/CT

Yoon, H., Kang, K. W., Chun, I. K., Cho, N., Im, S., Jeong-Yu, S., Lee, S., Jung, K. C., Lee, Y., Jeong, J. M., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2744-4 · Cited by 83 · see citing works

Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy

Chawla, S., Krejza, J., Vossough, A., Zhang, Y., Kapoor, G. S., Wang, S., O’Rourke, D. M., Melhem, E. R., & Poptani, H. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3384 · Cited by 82 · see citing works

Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma

Tykocinski, E. S., Grant, R. A., Kapoor, G. S., Krejza, J., Bohman, L., Gocke, T. A., Chawla, S., Halpern, C. H., Lopinto, J., Melhem, E. R., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos073 · Cited by 79 · see citing works

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer

Cho, A. E.-H., Hur, J., Moon, Y. W., Hong, S. R., Suh, Y. J., Kim, Y. J., Im, D. J., Hong, Y. J., Lee, H., Kim, Y. J., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2251-z · Cited by 78 · see citing works

Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma

Großmann, P., Gutman, D. A., Dunn, W. D., Holder, C. A., & Aerts, H. J. W. L. (2016) · BMC Cancer · doi:10.1186/s12885-016-2659-5 · Cited by 76 · see citing works

CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung

Ozkan, E., West, A., Dedelow, J. A., Chu, B. F., Zhao, W., Yildiz, V. O., Otterson, G. A., Shilo, K., Ghosh, S., King, M. A., et al. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.14147 · Cited by 75 · see citing works

18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis

Na, I. I., Byun, B. H., Kim, K. M., Cheon, G. J., Choe, D. H., Koh, J. S., Lee, D. Y., Ryoo, B., Baek, H., Lim, S. M., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.010 · Cited by 74 · see citing works

Multifunctional Imaging Signature for V-KI-RAS2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations in Colorectal Cancer

Miles, K. A., Ganeshan, B., Rodriguez‐Justo, M., Goh, V., Saad, Z. Z., Engledow, A., Meagher, M., Endozo, R., Taylor, S. A., Halligan, S., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120485 · Cited by 74 · see citing works

Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma

Huang, C., Yen, R., Cheng, M., Hsu, Y.-C., Wei, P., Tsai, Y., Tsai, M., Shih, J., Yang, C.-H., & Yang, P. (2009) · Medical Oncology · doi:10.1007/s12032-008-9160-1 · Cited by 74 · see citing works

Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis

Raza, S. M., Fuller, G. N., Rhee, C. H., Huang, S., Hess, K. R., Zhang, W., & Sawaya, R. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0155-3 · Cited by 74 · see citing works

Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI

Johnson, D. R., Diehn, F. E., Giannini, C., Jenkins, R. B., Jenkins, S. M., Parney, I. F., & Kaufmann, T. J. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5070 · Cited by 74 · see citing works

Value of 18F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma

Ko, K., Hsu, H., Huang, T.-W., Gao, H., Shen, D. H.-Y., Chang, W., Hsu, Y., Chang, T., Chu, C., Ho, C.-L., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2802-y · Cited by 70 · see citing works

Correlation Between EGFR Mutation Status and Computed Tomography Features in Patients With Advanced Pulmonary Adenocarcinoma

Hsu, J., Huang, M., Chen, C., Liu, G., Liu, T., Chong, I., Chou, S., & Yang, C. (2014) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000116 · Cited by 69 · see citing works

Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project

Colen, R. R., Vangel, M. G., Wang, J., Gutman, D. A., Hwang, S. N., Wintermark, M., Jain, R., Nicolas‐Jilwan, M., Chen, J. Y., Raghavan, P., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-30 · Cited by 68 · see citing works

Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification

Gupta, A. K., Young, R. J., Shah, A. D., Schweitzer, A. D., Graber, J. J., Shi, W., Zhang, Z., Huse, J. T., & Omuro, A. M. P. (2014) · Clinical Neuroradiology · doi:10.1007/s00062-014-0289-3 · Cited by 67 · see citing works

Adenocarcinomas with Predominant Ground-Glass Opacity: Correlation of Morphology and Molecular Biomarkers

Aoki, T., Hanamiya, M., Uramoto, H., Hisaoka, M., Yamashita, Y., & Korogi, Y. (2012) · Radiology · doi:10.1148/radiol.12111337 · Cited by 67 · see citing works

IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients

Métellus, P., Colin, C., Taïeb, D., Guedj, É., Nanni‐Metellus, I., de Paula, A. M., Colavolpe, C., Fuentes, S., Dufour, H., Barrie, M., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0625-2 · Cited by 66 · see citing works

Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival

Molina, D., Pérez-Beteta, J., Luque, B., Arregui, E., Calvo, M., Moreno, J. M. B., López, C., Martino, J., Velásquez, C., Asenjo, B., et al. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160242 · Cited by 65 · see citing works

The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma

Jamshidi, N., Jonasch, E. W., Zapala, M. A., Korn, R. L., Aganović, L., Zhao, H., Sitaram, R. T., Tibshirani, R. J., Banerjee, S., Brooks, J. D., et al. (2015) · Radiology · doi:10.1148/radiol.2015150800 · Cited by 64 · see citing works

18F-FDG PET/CT imaging in rectal cancer: relationship with theRASmutational status

Lovinfosse, P., Koopmansch, B., Lambert, F., Jodogne, S., Kustermans, G., Hatt, M., Visvikis, D., Seidel, L., Polus, M., Albert, A., et al. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160212 · Cited by 63 · see citing works

Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary Adenocarcinoma

Yano, M., Sasaki, H., Kobayashi, Y., et al. (2006) · Journal of Thoracic Oncology · doi:10.1097/01243894-200606000-00006 · Cited by 63 · see citing works

Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features?

Glynn, C., Zakowski, M. F., & Ginsberg, M. S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ce9a7a · Cited by 62 · see citing works

Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel‐based radiographic study of 146 low‐grade gliomas

Wang, Y., Zhang, T. Y., Li, S., Fan, X., Ma, J., Wang, L., & Jiang, T. (2014) · European Journal of Neurology · doi:10.1111/ene.12578 · Cited by 62 · see citing works

Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?

Halpenny, D. F., Riely, G. J., Hayes, S. A., Yu, H. A., Zheng, J., Moskowitz, C. S., & Ginsberg, M. S. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.09.007 · Cited by 62 · see citing works

Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous Ovarian Cancer: A Hypothesis-generating Study

Vargas, H. A., Miccò, M., Hong, S. I., Goldman, D. A., Dao, F., Weigelt, B., Soslow, R. A., Hricak, H., Levine, D. A., & Sala, E. (2014) · Radiology · doi:10.1148/radiol.14141477 · Cited by 61 · see citing works

Radiological features combined withIDH1status for predicting the survival outcome of glioblastoma patients

Wang, K., Wang, Y., Fan, X., Wang, J., Li, G., Ma, J., Ma, J., Jiang, T., & Dai, J. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov239 · Cited by 59 · see citing works

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status

Kapoor, G. S., Gocke, T. A., Chawla, S., Whitmore, R. G., Nabavizadeh, A., Krejza, J., Lopinto, J., Plaum, J., Maloney‐Wilensky, E., Poptani, H., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9880-x · Cited by 58 · see citing works

Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas

Saito, T., Muragaki, Y., Maruyama, T., Komori, T., Tamura, M., Nitta, M., Tsuzuki, S., & Kawamata, T. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0249-5 · Cited by 58 · see citing works

A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores

Wan, T., Bloch, B., Plecha, D. M., Thompson, C. L., Gilmore, H. L., Jaffe, C. C., Harris, L. N., & Madabhushi, A. (2016) · Scientific Reports · doi:10.1038/srep21394 · Cited by 58 · see citing works

Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes

Hong, S. J., Kim, T. J., Choi, Y. W., Park, J., Chung, J.-H., & Lee, K. W. (2016) · European Radiology · doi:10.1007/s00330-015-4196-z · Cited by 57 · see citing works

Predicting MGMT Methylation Status of Glioblastomas from MRI Texture

Levner, I., Drabycz, S., Roldán, G. B., de Robles, P. A., Cairncross, J. G., & Mitchell, R. (2009) · Lecture notes in computer science · doi:10.1007/978-3-642-04271-3_64 · Cited by 56 · see citing works

Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations

Kim, T. J., Lee, C., Jheon, S. H., Park, J., & Chung, J.-H. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.07.062 · Cited by 56 · see citing works

MRI features of extraskeletal myxoid chondrosarcoma

Tateishi, U., Hasegawa, T., Nojima, T., Takegami, T., & Arai, Y. (2005) · Skeletal Radiology · doi:10.1007/s00256-005-0021-0 · Cited by 55 · see citing works

Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours

Kim, J. W., Park, C., Park, S., Kim, Y. H., Han, J., Kim, C., Sohn, C., Chang, K., & Jung, H. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.178806 · Cited by 55 · see citing works

T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status

Perez, J. A., Thomas, A. A., Kaley, T. J., Lyo, J. K., Peck, K. K., Holodny, A. I., Mellinghoff, I. K., Shi, W., Zhang, Z., & Young, R. J. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4484 · Cited by 53 · see citing works

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis

Cheng, H., Yue, W., Xie, C., Zhang, R., Hu, S., & Wang, Z. (2013) · Tumor Biology · doi:10.1007/s13277-013-0934-5 · Cited by 53 · see citing works

Breast MRI radiogenomics: Current status and research implications

Grimm, L. J. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25116 · Cited by 53 · see citing works

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An 18F-FDG PET Study

Nagarajah, J., Ho, A. L., Tuttle, R. M., Weber, W., & Grewal, R. K. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.150607 · Cited by 51 · see citing works

NF-κB protein expression associates with 18F-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism

Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. B. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.001 · Cited by 51 · see citing works

Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS‐MLPA in patients with glioblastoma multiforme

Sunwoo, L., Choi, S. H., Park, C., Kim, J. W., Yi, K. S., Lee, W. J., Yoon, T. J., Song, S. W., Kim, J., Kim, J. Y., et al. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23838 · Cited by 51 · see citing works

FDG Uptake in Non–Small Cell Lung Cancer Is Not an Independent Predictor of EGFR or KRAS Mutation Status

Lee, S. M., Bae, S. K., Jung, S. J., & Kim, C. K. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000975 · Cited by 51 · see citing works

Tumor blood flow from arterial spin labeling perfusion MRI: A key parameter in distinguishing high‐grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high‐grade gliomas

Yoo, R., Choi, S. H., Cho, H. R., Kim, T. M., Lee, S., Park, C., Park, S., Kim, I. H., Yun, T. J., Kim, J., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24026 · Cited by 50 · see citing works

A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma

Rao, A. U. K., Rao, G., Gutman, D. A., Flanders, A. E., Hwang, S. N., Rubin, D. L., Colen, R. R., Zinn, P. O., Jain, R., Wintermark, M., et al. (2015) · Journal of neurosurgery · doi:10.3171/2015.4.jns142732 · Cited by 49 · see citing works

Correlation Between PET/CT Parameters and KRAS Expression in Colorectal Cancer

Chen, S.-W., Chiang, H.-C., Chen, W. T., Hsieh, T., Yen, K., Chiang, S., & Kao, C. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000481 · Cited by 49 · see citing works

Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns

Hsu, K.-H., Chen, K., Yang, T., Yeh, Y., Chou, T., Chen, H., Tsai, C.-R., Chen, C., Hsu, C.-P., Hsia, J., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821667b0 · Cited by 48 · see citing works

Prediction of Low versus High Recurrence Scores in Estrogen Receptor–Positive, Lymph Node–Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores

Dialani, V. M., Gaur, S. K., Mehta, T. S., Venkataraman, S., Fein-Zachary, V. J., Phillips, J., Brook, A., & Slanetz, P. J. (2016) · Radiology · doi:10.1148/radiol.2016151149 · Cited by 47 · see citing works

Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma

Lanic, H., Mareschal, S., Mechken, F., Picquenot, J., Cornic, M., Maingonnat, C., Bertrand, P., Clatot, F., Bohers, É., Stamatoullas, A., et al. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.600482 · Cited by 46 · see citing works

Air bronchogram: A potential indicator of epidermal growth factor receptor mutation in pulmonary subsolid nodules

Dai, J., Shi, J., Soodeen-Lalloo, A. K., Zhang, P., Yang, Y., Wu, C., Jiang, S., Jia, X., Fei, K., & Jiang, G. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.009 · Cited by 46 · see citing works

Imaging Genomics of Glioblastoma

Elbanan, M., Amer, A. M., Zinn, P. O., & Colen, R. R. (2014) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2014.09.010 · Cited by 44 · see citing works

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer

Shi, S., Ji, S., Qin, Y., Xu, J., Zhang, B., Xu, W., Liu, J., Long, J., Liu, C., Liu, L., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.014 · Cited by 43 · see citing works

Potential Role of Preoperative Conventional MRI Including Diffusion Measurements in Assessing Epidermal Growth Factor Receptor Gene Amplification Status in Patients with Glioblastoma

Young, R. J., Gupta, A. K., Shah, A. D., Graber, J. J., Schweitzer, A. D., Prager, A. J., Shi, W., Zhang, Z., Huse, J. T., & Omuro, A. M. P. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3604 · Cited by 43 · see citing works

Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study

Jain, R., Poisson, L., Narang, J., Scarpace, L. M., Rosenblum, M. L., Rempel, S. A., & Mikkelsen, T. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2956 · Cited by 43 · see citing works

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method

Rundle‐Thiele, D., Day, B. W., Stringer, B. W., Fay, M. F., Martin, J. H., Jeffree, R. L., Thomas, P. A., Bell, C., Salvado, O., Gal, Y., et al. (2015) · Journal of Medical Radiation Sciences · doi:10.1002/jmrs.103 · Cited by 42 · see citing works

Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation

Lazović, J., Soto, H., Piccioni, D. E., Ru, J. R. L., Li, S., Mirsadraei, L., Yong, W. H., Prins, R. M., Liau, L. M., Ellingson, B. M., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos258 · Cited by 42 · see citing works

Molecular Pathways: Targeting the PI3K Pathway in Cancer—BET Inhibitors to the Rescue

Στρατικόπουλος, Η., & Parsons, R. E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2389 · Cited by 42 · see citing works

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma

Jangchul, P., Kobayashi, Y., Urayama, K. Y., Yamaura, H., Yatabe, Y., & Hida, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161081 · Cited by 42 · see citing works

Multi-gene classifiers for prediction of recurrence in breast cancer patients

Naoi, Y., & Noguchi, S. (2015) · Breast Cancer · doi:10.1007/s12282-015-0596-9 · Cited by 41 · see citing works

Prediction of KRAS Mutation in Rectal Cancer Using MRI

Shin, Y. R., Kim, K. A., Im, S., Hwang, S. S., & KIM, K. (2016) · Anticancer Research · doi:10.21873/anticanres.11039 · Cited by 41 · see citing works

Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment

Mehta, S., Hughes, N. P., Li, S., Jubb, A. M., Adams, R. F., Lord, S., Koumakis, L., van Stiphout, R. G. P. M., Padhani, A. R., Makris, A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.017 · Cited by 39 · see citing works

Clear Cell Renal Cell Carcinoma: Multiphasic Multidetector CT Imaging Features Help Predict Genetic Karyotypes

Sauk, S., Hsu, M. S., Margolis, D., Lu, D., Rao, N. P., Belldegrun, A. S., Pantuck, A. J., & Raman, S. S. (2011) · Radiology · doi:10.1148/radiol.11101508 · Cited by 38 · see citing works

Correlation between computed tomography findings and epidermal growth factor receptor and Kras gene mutations in patients with pulmonary adenocarcinoma

Shimizu, K. (2011) · Oncology Reports · doi:10.3892/or.2011.1412 · Cited by 37 · see citing works

Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study

Qian, X., Tan, H., Zhang, J., Liu, K., Yang, T., Wang, M., Debinskie, W., Zhao, W., Chan, M. D., & Zhou, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10553 · Cited by 36 · see citing works

Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.

Krikelis, D., Skoura, E. V., Kotoula, V., Rondogianni, P., Pianou, N. K., Samartzis, A. P., Xanthakis, I., Fountzilas, G., & Datseris, I. (2014) · PubMed · Cited by 35 · see citing works

The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial

Jamshidi, N., Jonasch, E. W., Zapala, M. A., Korn, R. L., Brooks, J. D., Ljungberg, B., & Kuo, M. (2015) · European Radiology · doi:10.1007/s00330-015-4082-8 · Cited by 35 · see citing works

Molecular Mechanism Underlying the Detection of Colorectal Cancer by 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography

Izuishi, K., Yamamoto, Y., Sano, T., Takebayashi, R., Nishiyama, Y., Mori, H., Masaki, T., Morishita, A., & Suzuki, Y. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1727-z · Cited by 34 · see citing works

Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors

Narang, J., Jain, R., Scarpace, L. M., Saksena, S., Schultz, L. R., Rock, J. P., Rosenblum, M. L., Patel, S. C., & Mikkelsen, T. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0317-3 · Cited by 34 · see citing works

How clinical imaging can assess cancer biology

García‐Figueiras, R., Baleato‐González, S., Padhani, A. R., Luna, A., Casas, J. A. V., Sala, E., Vilanova, J. C., Koh, D., Herranz-Carnero, M., & Vargas, H. A. (2019) · Insights into Imaging · doi:10.1186/s13244-019-0703-0 · Cited by 126 · see citing works

Radiomics in stratification of pancreatic cystic lesions: Machine learning in action

Dalal, V., Carmicheal, J., Dhaliwal, A., Jain, M., Kaur, S., & Batra, S. K. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.023 · Cited by 111 · see citing works

Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer

Kirienko, M., Sollini, M., Corbetta, M., Voulaz, E., Gozzi, N., Interlenghi, M., Gallivanone, F., Castiglioni, I., Asselta, R., Duga, S., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05371-7 · Cited by 107 · see citing works

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer

Jiang, L., You, C., Xiao, Y., Wang, H., Su, G.-H., Xia, B., Zheng, R., Zhang, D., Jiang, Y., Gu, Y., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100694 · Cited by 101 · see citing works

Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review)

Trivizakis, E., Papadakis, G. Z., Souglakos, I., Papanikolaou, N. K., Koumakis, L., Spandidos, D. A., Tsatsakis, A. M., Karantanas, A. H., & Kostas Marias, A. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5063 · Cited by 93 · see citing works

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review

Ferro, M., Crocetto, F., Barone, B., Giudice, F. D., Maggi, M., Lucarelli, G. T., Busetto, G. M., Riccardo Autorino, B., Marchioni, M., Cantiello, F., et al. (2023) · Therapeutic Advances in Urology · doi:10.1177/17562872231164803 · Cited by 83 · see citing works

TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review

Zanfardino, M., Pane, K., Mirabelli, P., Salvatore, M., & Franzese, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236033 · Cited by 75 · see citing works

Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review

Ninatti, G., Kirienko, M., Neri, E., Sollini, M., & Chiti, A. (2020) · Diagnostics · doi:10.3390/diagnostics10060359 · Cited by 70 · see citing works

Omics Technologies Improving Breast Cancer Research and Diagnostics

Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52 · see citing works

Arterial spin labelling and diffusion-weighted imaging in paediatric brain tumours

Hales, P. W., D’Arco, F., Cooper, J., Pfeuffer, J., Hargrave, D. R., Mankad, K., & Clark, C. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101696 · Cited by 50 · see citing works

Image-based biomarkers for solid tumor quantification

Savadjiev, P., Chong, J., Dohan, A. J. J., Agnus, V., Forghani, R., Reinhold, C., & Gallix, B. (2019) · European Radiology · doi:10.1007/s00330-019-06169-w · Cited by 41 · see citing works

Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma

Zeng, H., Chen, L., Wang, M., Luo, Y., Huang, Y., & Ma, X. (2021) · Aging · doi:10.18632/aging.202752 · Cited by 41 · see citing works

Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma

Veeraraghavan, H., Vargas, H., Jiménez-Sánchez, A., Miccò, M., Mema, E., Lakhman, Y., Crispin‐Ortuzar, M., Huang, E. P., Levine, D. A., Grisham, R. N., et al. (2020) · Cancers · doi:10.3390/cancers12113403 · Cited by 38 · see citing works

Radiomics Prediction of EGFR Status in Lung Cancer—Our Experience in Using Multiple Feature Extractors and The Cancer Imaging Archive Data

Lü, L., Sun, S. H., Yang, H., Linning, E., Guo, P., Schwartz, L. H., & Zhao, B. (2020) · Tomography · doi:10.18383/j.tom.2020.00017 · Cited by 36 · see citing works

Association of image‐defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma

Temple, W. C., Vo, K. T., Matthay, K. K., Balliu, B., Coleman, C., Michlitsch, J., Phelps, A. S., Behr, S. C., & Zapala, M. A. (2020) · Cancer Medicine · doi:10.1002/cam4.3663 · Cited by 37 · see citing works

Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features

Cen, D., Xu, L., Zhang, S., Chen, Z., Huang, Y. X., Li, Z., & Liang, B. (2019) · European Radiology · doi:10.1007/s00330-019-06049-3 · Cited by 30 · see citing works

The surgical perspective in precision treatment of diffuse gliomas

Thon, N., Tonn, J., & Kreth, F.-W. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s174316 · Cited by 28 · see citing works

Extendable and explainable deep learning for pan-cancer radiogenomics research

Liu, Q., & Hu, P. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.102111 · Cited by 27 · see citing works

Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study

Lee, H. W., Cho, H.-H., Joung, J., Jeon, H. G., Jeong, B. C., Jeon, S. S., Lee, H. M., Nam, D., Park, W., Kim, C. K., et al. (2020) · Cancers · doi:10.3390/cancers12040866 · Cited by 25 · see citing works

What can artificial intelligence teach us about the molecular mechanisms underlying disease?

Cook, G., & Goh, V. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04370-z · Cited by 20 · see citing works

Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know

Serrão, E. M., Klug, M., Moloney, B., Jhaveri, A., Gullo, R. L., Pinker, K., Luker, G. D., Haider, M. A., Shinagare, A. B., & Liu, X. (2023) · Radiology Imaging Cancer · doi:10.1148/rycan.220153 · Cited by 20 · see citing works

18F-FDG PET/CT imaging of pediatric peripheral neuroblastic tumor: a combined model to predict the International Neuroblastoma Pathology Classification

Qian, L., Feng, L., Zhang, S.-X., Liu, J., Ren, J., Liu, L., Zhang, H., & Yang, J. (2022) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-343 · Cited by 17 · see citing works

BTDNet: A Multi-Modal Approach for Brain Tumor Radiogenomic Classification

Kollias, D., Vendal, K., Gadhavi, P., & Russom, S. (2023) · Applied Sciences · doi:10.3390/app132111984 · Cited by 15 · see citing works

Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies

Katabathina, V. S., Marji, H., Khanna, L., Ramani, N. S., Yedururi, S., Dasyam, A. K., Menias, C. O., & Prasad, S. R. (2020) · Radiographics · doi:10.1148/rg.2020200042 · Cited by 15 · see citing works

Regulation of biomarker analysis: what can be translated in the clinic?

Diamantopoulos, M. A., Boti, M. A., Sarri, T., Tounias, G., Psychogyiou, D. D., & Scorilas, A. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2534962 · Cited by 14 · see citing works

Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine

Sanchez, I., & Rahman, R. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01580-z · Cited by 13 · see citing works

Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma

Deng, Y., Chen, X., Huang, C., Song, J. H., Feng, S., Chen, X., & Zhou, R. (2022) · Journal of Oncology · doi:10.1155/2022/3794021 · Cited by 13 · see citing works

Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients

Jahromi, A. H., Barkauskas, D. A., Zabel, M. K., Goodman, A. M., Frampton, G. M., Nikanjam, M., Hoh, C. K., & Kurzrock, R. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00732-z · Cited by 13 · see citing works

The Prediction of Biological Features Using Magnetic Resonance Imaging in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

van der Hulst, H. J., Jansen, R. W., Vens, C., Bos, P., Schats, W., de Jong, M. C., Martens, R. M., Bodalal, Z., Beets‐Tan, R. G. H., van den Brekel, M. W. M., et al. (2023) · Cancers · doi:10.3390/cancers15205077 · Cited by 12 · see citing works

Imaging biomarkers in upper gastrointestinal cancers

Gabelloni, M., Faggioni, L., & Neri, E. (2019) · BJR|Open · doi:10.1259/bjro.20190001 · Cited by 12 · see citing works

PET/MRI and genetic intrapatient heterogeneity in head and neck cancers

Clasen, K., Leibfarth, S., Hilke, F. J., Admard, J., Winter, R. M., Welz, S., Gatidis, S., Nann, D., Ossowski, S., Breuer, T., et al. (2020) · Strahlentherapie und Onkologie · doi:10.1007/s00066-020-01606-y · Cited by 12 · see citing works

Use of Precision Imaging in the Evaluation of Pancreas Cancer

Korn, R. L., Rahmanuddin, S., & Borazanci, E. H. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-16391-4_8 · Cited by 11 · see citing works

Radiogenomics Based on PET Imaging

Park, Y. J., Shin, M., & Moon, S. H. (2020) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-020-00642-x · Cited by 9 · see citing works

Radiogenomics as association between non-invasive imaging features and molecular genomics of lung cancer

Rizzo, S., Savoldi, F., Rossi, D., & Bellomi, M. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.17 · Cited by 9 · see citing works

Development of Pd-Loaded Hf-Based Metal–Organic Framework as a Dual-Modal Contrast Agent for Photoacoustic Imaging and Computed Tomography

Chen, Y., Yu, Y., Wang, Y., Kumar, R. K. R., Lee, C.-Y., Chuang, C., Liao, L., & Wu, K. C. ‐. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00169 · Cited by 8 · see citing works

Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors

Khanyile, R., Chipiti, T., Hull, R., & Dlamini, Z. (2025) · Cancers · doi:10.3390/cancers17050808 · Cited by 7 · see citing works

Correlation of gene expression with magnetic resonance imaging features of retinoblastoma: a multi-center radiogenomics validation study

Jansen, R. W., Roohollahi, K., Uner, O. E., de Jong, Y., de Bloeme, C. M., Göricke, S. L., Sirin, S., Maeder, P. P., Galluzzi, P., Brisse, H. J., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10054-y · Cited by 7 · see citing works

Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery

Kuno, M., Osumi, H., Udagawa, S., Yoshikawa, K., Ooki, A., Shinozaki, E., Ishikawa, T., Oba, J., Yamaguchi, K., & Sakurada, K. (2025) · Current Oncology · doi:10.3390/curroncol32110588 · Cited by 7 · see citing works

Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions

O’Sullivan, N. J., & Kelly, M. E. (2023) · Current Oncology · doi:10.3390/curroncol30050372 · Cited by 6 · see citing works

Ultrasound-based radiogenomics: status, applications, and future direction

Wang, S.-R., Shen, Y.-T., Huang, B., & Xu, H. (2025) · ULTRASONOGRAPHY · doi:10.14366/usg.24152 · Cited by 5 · see citing works

Radiomics and Imaging Genomics for Evaluation of Tumor Response

Lee, G., Bak, S., Lee, H., Choi, J., & Park, H. (2020) · Medical radiology · doi:10.1007/978-3-030-31171-1_13 · Cited by 5 · see citing works

Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma

Liu, Z., & Zhang, J. (2020) · BMC Neurology · doi:10.1186/s12883-020-01838-6 · Cited by 5 · see citing works

Standardized uptake value (SUVmax) in 18F-FDG PET/CT is correlated with the total number of main oncogenic anomalies in cancer patients

Jahromi, A. H., Chang, G. H., Kurzrock, R., & Hoh, C. K. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1834793 · Cited by 4 · see citing works

Construction of a radiogenomic association map of pancreatic ductal adenocarcinoma

Jamshidi, N., Senthilvelan, J., Dawson, D. W., Donahue, T. R., & Kuo, M. (2023) · BMC Cancer · doi:10.1186/s12885-023-10658-z · Cited by 3 · see citing works

Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging

Berghe, T. V. D., Verberckmoes, B., Kint, N., Wallaert, S., Vos, N. D., Algoet, C., Behaeghe, M., Dutoit, J. C., Roy, N. V., Vlummens, P., et al. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01672-1 · Cited by 3 · see citing works

Decoding Lung Cancer Radiogenomics: A Custom Clustering/Classification Methodology to Simultaneously Identify Important Imaging Features and Relevant Genes

Provenzano, D., Lichtenberger, J. P., Goyal, S., & Rao, Y. J. (2025) · Applied Sciences · doi:10.3390/app15074053 · Cited by 2 · see citing works

Predicting podoplanin expression and prognostic significance in high-grade glioma based on TCGA TCIA radiomics

Long, S., Xu, H., Li, M., Wang, L., Jiang, J., Wei, W., & Li, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325964 · Cited by 2 · see citing works

Radiological biomarkers of brain gliomas

Tyurina, A. N., Вихрова, Н. Б., Batalov, A. I., Kalaeva, D. B., Shults, E. I., Postnov, A. A., & Pronin, I. (2022) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro202286061121 · Cited by 2 · see citing works

Neuroimaging of Brain Tumors in the Era of Radiogenomics

Batchala, P. P., Muttikkal, T. J. E., Donahue, J., Lopes, M. B. S., Williams, E. S., Tustison, N. J., & Patel, S. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_54 · Cited by 2 · see citing works

A Review on the Applications and Implications of Artificial Intelligence and Machine Learning in Oncology

Hiwase, K., Verma, P., Zade, N. R., Kumar, P., Weerarathna, I. N., & Gundewar, S. K. (2026) · International Journal of Computational Intelligence Systems · doi:10.1007/s44196-026-01164-8 · Cited by 2 · see citing works

Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer

Guan, W., Chen, J., Zeng, X., Chen, Y., Liu, B., Xin, P., Huang, Z., Chen, W., Zheng, Y., Chen, J., et al. (2026) · PeerJ · doi:10.7717/peerj.21579 · Cited by 1 · see citing works

The Application of AI in Precision Oncology: Tailoring Diagnosis, Treatment, and the Monitoring of Disease Progression to the Patient

Dlamini, Z., & Hull, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-21506-3_1 · Cited by 2 · see citing works

Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on 18F-FDG PET/CT

Zhang, Y., Hu, Y.-X., Zhao, S., & Xu, S.-S. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04226-7 · Cited by 1 · see citing works

Advances in Imaging in Ocular Oncology: A Radiologist’s Perspective

de Graaf, P., Jansen, R. W., Galluzzi, P., & de Jong, M. C. (2022) · Springer eBooks · doi:10.1007/978-3-031-08250-4_10 · Cited by 1 · see citing works

Invited Commentary: Radiogenomics Applied to Select Abdominal Tumors

Luna, A. (2020) · Radiographics · doi:10.1148/rg.2020200194 · Cited by 1 · see citing works

Radiomics and gene expression profile to characterize the disease and predict outcome in patients with lung cancerPreprint

Kirienko, M., Sollini, M., Corbetta, M., Voulaz, E., Gozzi, N., Interlenghi, M., Gallivanone, F., Castiglioni, I., Asselta, R., Duga, S., et al. (2021) · doi:10.21203/rs.3.rs-157951/v1 · Cited by 1 · see citing works

Estimation of 18F-FDG PET Image Texture Features for Metastasis Prediction in Non-Small Cell Lung Cancer Using Epithelial Mesenchymal Transition-Related GenesPreprint

Kim, B.-C., Lim, I., Byun, B. H., Kim, J.-G., & Woo, S. (2020) · Research Square · doi:10.21203/rs.3.rs-104417/v1

A metastasis prediction model in non-small cell lung cancer using GLCM_contrast and epithelial mesenchymal transition related genesPreprint

Kim, B.-C., Lim, I., Byun, B. H., Kim, J.-G., & Woo, S. (2021) · Research Square · doi:10.21203/rs.3.rs-268933/v1

rCBV and ADC based grading of gliomas with glimpse into radiogenomics

Rohilla, S., Deodurg, A. R., Kanakavvanavar, P. S., Singh, I., Gupta, V., & Dhaulakhandi, D. B. (2021) · Romanian Neurosurgery · doi:10.33962/roneuro-2021-009

Breast cancer and its genetic heterogeneity at single cell level: A concise perspective of cellular architecture and taxonomy

Sharma, R., Parihar, N., Gopi, K., Yadav, V., Sharma, P., Garg, V. K., Okpala, C. O. R., Buttar, H. S., Thakur, S., Goel, N., et al. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24838-2.00006-9

Radiogenomics and Artificial Intelligence in Health and Diseases

Aalam, S. W., Ahanger, A. B., Majeed, T., Ahanger, A. N., Assad, A., Macha, M. A., & Bhat, M. R. (2025) · Springer eBooks · doi:10.1007/978-981-96-8176-1_8

Caractérisation multiparamétrique des cancers colorectaux

Badic, B. (2018) · doi:10.70675/d883e26cz7702z4d72z8967za708748d5374

MRI-Based Radiomics Model for Pretreatment Prediction of Pathological Lymph Node Metastasis in Neuroendocrine Carcinoma of the Cervix: Dual-Center Development and External Validation

Chen, J., Jiang, F., 陈兴发, Lin, R., Ma, N., Yu, H., & Sun, Y. (2026) · Current Oncology · doi:10.3390/curroncol33100625

Background, current role, and potential applications of radiogenomics

Pinker, K., Shitano, F., Sala, E., Do, R. K., Young, R. J., Wibmer, A. G., Hricak, H., Sutton, E. J., & Morris, E. A. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25870 · Cited by 184 · see citing works

Biomedical image characterization and radiogenomics

Fan, M., Zhu, Y., Li, L., Clarke, R. C., & Wang, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816034-3.00018-3 · Cited by 1 · see citing works

Radiogenomics: a key component of precision cancer medicine

Liu, Z.-Q., Duan, T., Zhang, Y.-Y., Weng, S.-Y., Xu, H.-X., Ren, Y.-Q., Zhang, Z.-Y., & Han, X.-W. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02317-8 · Cited by 98 · see citing works

Radiogenomics: bridging the gap between imaging and genomics for precision oncology

He, W., Huang, W., Zhang, L., Wu, X.-W., Zhang, S.-X., & Zhang, B. (2024) · MedComm · doi:10.1002/mco2.722 · Cited by 65 · see citing works

Radiogenomics and the Integration of Imaging and Genomic Data

Khan, A., Mathew, J., Hasham, I. M., & Liu, H. (2026) · CRC Press eBooks · doi:10.1201/9781003679028-26